FDA Hands Out Fast-Track Voucher for Kids' Hearing Loss Drug
Published Date: 5/6/2026
Notice
Summary
The FDA just gave Regeneron a special priority review voucher for their new rare pediatric disease treatment, OTARMENI, approved on April 23, 2026. This voucher speeds up future FDA reviews, helping get important medicines to kids and adults with severe hearing loss faster. It’s a big win for patients and could save time and money in bringing new treatments to market.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
OTARMENI approved for OTOF hearing loss
You or your child with severe-to-profound sensorineural hearing loss may be eligible for OTARMENI, which the FDA approved on April 23, 2026. The approval covers pediatric and adult patients with any frequency >90 dB HL who have molecularly confirmed biallelic variants in the OTOF gene, preserved outer hair cell function, and no prior cochlear implant in the same ear.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20063, Request for Nominations for Voting Members of Food and Drug Administration Advisory Committees
The FDA is looking for smart, qualified people to join its advisory committees and help make important decisions about food and drugs. If you have the right skills, you can apply anytime, but get your nomination in by November 30, 2026, for the best chance at current openings. This is a great chance to influence public health without any cost to you!
Previous / Next Documents
Previous: 2026-08906, Automated Commercial Environment (ACE) Export Manifest for Air Cargo Test: Renewal of Test
U.S. Customs and Border Protection is renewing its fun and helpful test that lets air cargo exporters send their shipment info electronically before loading. This test, which started in 2015 and keeps getting extended, will now run for two more years starting May 6, 2026. If you’re involved in air cargo exports, you can join anytime and help shape the future of faster, smoother customs processing—no extra fees involved!
Next: 2026-08933, Renewal of Department of War Federal Advisory Committee-Department of the Air Force Scientific Advisory Board
The Department of War is renewing the Air Force Scientific Advisory Board to keep getting expert advice on science and technology. This group helps the Air Force stay sharp and innovative, with an annual budget of about $3.9 million. The renewal means the board will keep meeting and advising for the next few years, making sure the Air Force stays ahead in cool tech and defense.